April 21, 2021
Oncolys BioPharma said on April 20 that it has entered a joint development agreement with Japanese CRO Shin Nippon Biomedical Laboratories for its COVID-19 infection treatment OBP-2011. The financial terms of the agreement have not been disclosed. Preclinical studies of...read more